SHANNON WHEELER: Open Payments
NPI 1962816330 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$245 in 10 payments from 6 companies in 2025. Trend: 2023 $572 · 2024 $316 · 2025 $245
Food & beverage: $245
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $87 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| UCB, Inc. | 1 | $41 |
| ACADIA Pharmaceuticals Inc | 2 | $39 |
| Amgen Inc. | 1 | $16 |
| Biogen, Inc. | 1 | $16 |
Products named: LEQVIO, Briviact, FABRAZYME, NUPLAZID, REPATHA, TYSABRI.
Industry payments across TX — which companies pay providers there.
